Market Research Services for the Pharmaceutical, Food and MedTech Industries

Business strategy, positioning, and marketing execution geared towards regulated markets and long decision-making cycles in Europe and Latin America.

Market research and marketing cannot be treated as an isolated or purely promotional function. They need to engage with regulation, market access, compliance, distribution channels, and the scientific maturity of the product portfolio.

ELS Group’s Marketing Consulting service is designed to support pharmaceutical, medical device, supplement, cosmetic, and medicinal cannabis companies in building solid commercial strategies that are compatible with highly regulated environments and have a real impact on sustainable growth.

Scope of Market Research Services for the Pharmaceutical Industry by ELS Group

ELS Group operates with an integrated vision encompassing marketing, regulation, quality, distribution, and corporate strategy. This ensures that business decisions are viable not only from a marketing perspective, but also from a regulatory, operational, and financial standpoint.

Before any marketing or expansion plan, we assess the true size of the market, going beyond generic estimates. The pharmaceutical consulting firm ELS Group conducts in-depth analyses of the industry, margins, value chain, and competitive dynamics, ensuring decisions are based on operational reality.

This work includes:

  • Realistic sizing of the target market
  • Industry analysis, margins and value chain.
  • Technical and commercial alignment of sales forecasts.
  • Quick market analysis and product acceptance.
  • Identifying the main players and direct competitors.
  • Structured competitive comparison
  • Evaluation of reimbursement models
  • Identifying potential risks and barriers to access.

The performance of the pharmaceutical consulting firm ELS Group combines data intelligence, scientific evidence, and local context, allowing for strategies tailored to the specific country, therapeutic area, and product stage.

We structure strategic decisions based on real data regarding the use, access, and behavior of the healthcare market.

  • Customized market research and local syndicated reports.
  • Customer and competitor intelligence by therapeutic area and country.
  • Analysis of product use in different clinical contexts.
  • Epidemiological and market catalyst analysis
  • In-depth interviews, focus groups, and qualitative research.
  • Assessment of therapeutic specialization
  • Mapping local stakeholders: CMOs, CROs, KOLs, distributors, buyers, patient associations, PI agents, and wholesalers.
  • Support for market access and optimization of the risk-benefit ratio.

Internationalization demands more than just marketing: it requires governance, clear metrics, and coordinated execution. The pharmaceutical consulting firm ELS Group provides support from the design to the implementation of the process.

  • Creation, approval, and implementation of the internationalization process.
  • ELS Group's proprietary KPIs for internationalization
  • Detailed business planning by country.
  • Business insight, local regulatory compliance, and sales traction.
  • Strategic support for entry and consolidation in new markets.

In complex markets, generic predictions fail. We work with advanced and realistic models, considering regulatory, clinical, and commercial variables.

  • Sales forecasting studies in challenging markets
  • Price studies and margin analysis throughout the entire channel.
  • Impact assessment of public policies and reimbursement
  • Business scenario simulations

We integrate marketing, quality, and compliance, ensuring consistency between value proposition, execution, and real-world experience.

  • Customer feedback surveys integrated into the Quality Management System
  • Mapping the patient journey and patient-based forecasting models
  • Evaluation of service standards by country.
  • Intelligent Conjoint Analysis for Decision Support

The pharmaceutical consulting firm ELS Group also acts as a strategic partner in high-level decisions, supporting leadership and boards.

  • Development of the strategic marketing plan
  • Growth strategies by country, sub-industry and therapeutic area.
  • Value-based business models in healthcare
  • Digital health consulting
  • Market entry strategies
  • Strategic preparation and defense for boardrooms.

We support companies that need to structure, review, or accelerate their innovation processes in a sustainable and regulatory-sound manner.

  • Innovation process audit
  • Design and optimization of innovation flows.
  • Alignment between innovation, market and regulatory compliance
  • Business scenario simulations

When does market research become strategic for the pharmaceutical industry?

Market research becomes essential when a company faces challenges such as:

  • Entry into new markets or countries
  • Launch of regulated products
  • Poor commercial performance despite approved portfolio.
  • Need to reorganize distribution channels
  • Lack of clarity regarding positioning, value proposition, or target audience.
  • Unstructured growth or growth dependent on a few partners.

In these contexts, poorly founded marketing decisions lead to wasted resources, regulatory risks, and loss of competitiveness.

The structure behind the ELS Group's Market Research for the Pharmaceutical Industry

ELS Group’s performance in Marketing Consulting is supported by unique advantages that are uncommon in the market:

True integration between marketing, regulation, and quality.

Operational presence in 11 countries

Experience in highly regulated markets

Multisectoral activity (pharmaceuticals, medical devices, cosmetics, supplements, cannabis)

A strategic vision oriented towards the long term, not just one-off campaigns.

Direct support for execution, not just diagnosis.

These factors allow ELS Group to act as a strategic extension of the client’s marketing and business area.

Market Research as a Strategic Lever for the Pharmaceutical Industry

In the pharmaceutical industry, marketing involves strategy, positioning, trust, and consistent execution.

With ELS Group’s market research, your company will make informed, secure business decisions aligned with market and regulatory requirements, transforming marketing into a true driver of sustainable growth.

I want to speak to a Specialist

Frequently asked questions about marketing consulting services for the pharmaceutical industry.

We do both. We work from strategic diagnosis to supporting implementation and monitoring results.

Yes. This is one of the main differentiators of the ELS Group. All strategies are designed considering compliance and regulatory feasibility.

ELS Group operates internationally, with a presence in 11 countries, offering regulatory and quality support in Europe and Latin America.

The company has specialized local teams that work in an integrated manner with the main regulatory authorities in each region, allowing it to align global strategies with the specific regulatory requirements of each market.